Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Published safety observations Published experimental studies have generally reported favourable safety findings for BPC-157 within the investigated models
No, BPC-157 is not FDA-approved
Early data from amycretin showed up to 13.1% weight loss in just 36 weeks of a phase 1/2 trial, with the weight loss curve still descending steeply
With no head-to-head study, comparing the two requires stitching together trials that differ in population, comparator, endpoint, and duration a chain with several weak links
The fact that retatrutide passed its Phase 1 and Phase 2 trials means researchers deemed it safe enough for large-scale human testing
GH secretagogues work best on an empty stomach, ideally 2-3 hours after eating and 30 minutes before sleep
